CD5+ B cells with the features of subepithelial B cells found in human tonsils
- PMID: 17615580
- DOI: 10.1002/eji.200636887
CD5+ B cells with the features of subepithelial B cells found in human tonsils
Abstract
This study describes a CD5+ B cell that differs from the majority of the CD5+ B cells from human tonsils. This cell, isolated from in vivo activated B cells, expressed activation markers and featured a CD23-, IgMhigh, IgDlow surface phenotype, responded to T cell-independent type-2 antigens in vitro, and was detected in the subepithelial (SE) areas, the tonsil equivalent of the splenic marginal zone (MZ). Most of the cells utilized unmutated Ig VH genes, although cells with mutated genes also were found, a finding confirmed by single-cell studies. Mutated sequences were more frequent in suspensions enriched for CD27+ cells. Repeated VDJ gene sequences were observed in different molecular clones from the same cell suspension, suggesting in situ expansion. These CD5+ B cells seem to share features with previously characterized tonsil CD5- SE B cells and differ from the majority of tonsil CD5+ B cells, which have the surface phenotype of follicular mantle B cells, lack activation markers, do not respond to T cell-independent antigens, and utilize unmutated VH genes. These data are discussed considering the present views on the origin of B cell subset populations and the relationships between MZ and B1 cells.
Similar articles
-
Subepithelial B cells in the human palatine tonsil. I. Morphologic, cytochemical and phenotypic characterization.Eur J Immunol. 1996 Sep;26(9):2035-42. doi: 10.1002/eji.1830260911. Eur J Immunol. 1996. PMID: 8814243
-
Identification of two distinct CD5- B cell subsets from human tonsils with different responses to CD40 monoclonal antibody.Eur J Immunol. 1993 Apr;23(4):873-81. doi: 10.1002/eji.1830230416. Eur J Immunol. 1993. PMID: 7681401
-
Molecular single-cell analysis reveals that CD5-positive peripheral blood B cells in healthy humans are characterized by rearranged Vkappa genes lacking somatic mutation.J Clin Invest. 1997 Oct 1;100(7):1667-76. doi: 10.1172/JCI119691. J Clin Invest. 1997. PMID: 9312164 Free PMC article.
-
The CD5+ B-cell.Int J Biochem Cell Biol. 2004 Nov;36(11):2105-11. doi: 10.1016/j.biocel.2004.05.017. Int J Biochem Cell Biol. 2004. PMID: 15313456 Review.
-
[Heterogeneity and function of human B lymphocytes].Med Sci (Paris). 2006 Dec;22(12):1075-80. doi: 10.1051/medsci/200622121075. Med Sci (Paris). 2006. PMID: 17156729 Review. French.
Cited by
-
Cellular origin(s) of chronic lymphocytic leukemia: cautionary notes and additional considerations and possibilities.Blood. 2011 Feb 10;117(6):1781-91. doi: 10.1182/blood-2010-07-155663. Epub 2010 Dec 9. Blood. 2011. PMID: 21148333 Free PMC article. Review.
-
Cellular origin and pathophysiology of chronic lymphocytic leukemia.J Exp Med. 2012 Nov 19;209(12):2183-98. doi: 10.1084/jem.20120833. Epub 2012 Oct 22. J Exp Med. 2012. PMID: 23091163 Free PMC article.
-
KSHV infects a subset of human tonsillar B cells, driving proliferation and plasmablast differentiation.J Clin Invest. 2011 Feb;121(2):752-68. doi: 10.1172/JCI44185. Epub 2011 Jan 18. J Clin Invest. 2011. PMID: 21245574 Free PMC article.
-
Chronic Lymphocytic Leukemia B-Cell Normal Cellular Counterpart: Clues From a Functional Perspective.Front Immunol. 2018 Apr 4;9:683. doi: 10.3389/fimmu.2018.00683. eCollection 2018. Front Immunol. 2018. PMID: 29670635 Free PMC article. Review.
-
Imatinib treatment induces CD5+ B lymphocytes and IgM natural antibodies with anti-leukemic reactivity in patients with chronic myelogenous leukemia.PLoS One. 2011 Apr 18;6(4):e18925. doi: 10.1371/journal.pone.0018925. PLoS One. 2011. PMID: 21533122 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials